MMP-2 and MMP-9 expression was significantly higher in endometrial adenocarcinoma than that in hyperplastic and normal endometria.

MMP-2、MMP-9在子宫内膜腺癌中表达显著高于子宫内膜增生症和正常子宫内膜（P〈0.05）。

This article reviews its applications in the treatment of menorrhagia, endometriosis and adenomyosis as well as the endometria protection during hormone replacement therapy(HRT).

现就其在治疗月经过多、子宫内膜异位症和腺肌症、激素替代治疗期间的子宫内膜保护等方面进行综述。